ExactScience vs Pixelgen
Side-by-side comparison · Updated May 2026
| Description | Exact Sciences Corp. is a leading molecular diagnostics company focused on transforming cancer care through prevention, early detection, and treatment guidance. Their cutting-edge product portfolio includes non-invasive screening tests like Cologuard® for colorectal cancer, Oncotype DX® for predicting cancer recurrence, and OncoExTra® for genomic profiling. The company also offers Riskguard™ for hereditary cancer risk assessment and is pioneering multi-cancer early detection tests. Committed to innovation and scientific validation, Exact Sciences plays a pivotal role in cancer diagnostics, earning endorsements from clinical guidelines and continuous certification as a Great Place to Work®. | Pixelgen Technologies is pioneering 3D spatial analysis of cell surface proteins with its Molecular Pixelation (MPX) technology. This advanced technique enhances understanding of cell biology, disease mechanisms, and aids in drug and diagnostic development by offering unparalleled 3D spatial resolution and multiplexing capabilities. MPX allows for detailed examination of proteins' spatial relationships at single-cell levels, which is not feasible with traditional methods. Supporting high-resolution mapping, it is particularly beneficial in immunology and cancer research, facilitating efficient analysis via existing NGS workflows. This innovative technology is further bolstered by collaborations with BioLizard for optimized computational solutions. |
| Category | Healthcare | Healthcare |
| Rating | No reviews | No reviews |
| Pricing | Free | Pricing unavailable |
| Starting Price | Free | N/A |
| Plans |
| — |
| Use Cases |
|
|
| Tags | molecular diagnosticscancer carepreventionearly detectiontreatment guidance | 3D spatial analysisMolecular Pixelationcell surface proteinscell biologydisease mechanisms |
| Features | ||
| Comprehensive suite of cancer tests across the care continuum, including early detection and screening. | ||
| Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening. | ||
| Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment. | ||
| Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection. | ||
| Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits. | ||
| OncoExTra® test for aiding late-stage cancer therapy selection. | ||
| Supports patient and provider through logins for test ordering and results tracking. | ||
| Backed by extensive scientific research, publications, and clinical studies. | ||
| Engages in community outreach and health equity initiatives. | ||
| 3D spatial single-cell proteomics | ||
| High-resolution mapping of cell surface proteins | ||
| High multiplexing capability with DNA-tagged antibodies | ||
| Streamlined workflow compatible with NGS | ||
| Comprehensive data analysis with Pixelator software | ||
| Enhanced precision for drug discovery | ||
| Applications in immunology, cancer research, and diagnostics | ||
| Optimized computational solutions with BioLizard collaboration | ||
| Unparalleled spatial resolution | ||
| Seamless integration with existing workflows | ||
| View ExactScience | View Pixelgen | |
Modify This Comparison
Also Compare
Explore more head-to-head comparisons with ExactScience and Pixelgen.